These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 22283765)

  • 41. GABA Targets for the Treatment of Cognitive Dysfunction in Schizophrenia.
    Volk DW; Lewis DA
    Curr Neuropharmacol; 2005 Jan; 3(1):45-62. PubMed ID: 22545031
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Functional and anatomical aspects of prefrontal pathology in schizophrenia.
    Goldman-Rakic PS; Selemon LD
    Schizophr Bull; 1997; 23(3):437-58. PubMed ID: 9327508
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Subunit-selective modulation of GABA type A receptor neurotransmission and cognition in schizophrenia.
    Lewis DA; Cho RY; Carter CS; Eklund K; Forster S; Kelly MA; Montrose D
    Am J Psychiatry; 2008 Dec; 165(12):1585-93. PubMed ID: 18923067
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cortical deficits of glutamic acid decarboxylase 67 expression in schizophrenia: clinical, protein, and cell type-specific features.
    Curley AA; Arion D; Volk DW; Asafu-Adjei JK; Sampson AR; Fish KN; Lewis DA
    Am J Psychiatry; 2011 Sep; 168(9):921-9. PubMed ID: 21632647
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alterations in cortical interneurons and cognitive function in schizophrenia.
    Dienel SJ; Lewis DA
    Neurobiol Dis; 2019 Nov; 131():104208. PubMed ID: 29936230
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia.
    Eggan SM; Hashimoto T; Lewis DA
    Arch Gen Psychiatry; 2008 Jul; 65(7):772-84. PubMed ID: 18606950
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dopamine, the prefrontal cortex and schizophrenia.
    Knable MB; Weinberger DR
    J Psychopharmacol; 1997; 11(2):123-31. PubMed ID: 9208376
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Postnatal development of synaptic structure proteins in pyramidal neuron axon initial segments in monkey prefrontal cortex.
    Cruz DA; Lovallo EM; Stockton S; Rasband M; Lewis DA
    J Comp Neurol; 2009 Jun; 514(4):353-67. PubMed ID: 19330819
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Axo-axonic synapses formed by somatostatin-expressing GABAergic neurons in rat and monkey visual cortex.
    Gonchar Y; Turney S; Price JL; Burkhalter A
    J Comp Neurol; 2002 Jan; 443(1):1-14. PubMed ID: 11793343
    [TBL] [Abstract][Full Text] [Related]  

  • 50. GABA is a modulator, rather than a classical transmitter, in the medial nucleus of the trapezoid body-lateral superior olive sound localization circuit.
    Fischer AU; Müller NIC; Deller T; Del Turco D; Fisch JO; Griesemer D; Kattler K; Maraslioglu A; Roemer V; Xu-Friedman MA; Walter J; Friauf E
    J Physiol; 2019 Apr; 597(8):2269-2295. PubMed ID: 30776090
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophrenia.
    Beneyto M; Abbott A; Hashimoto T; Lewis DA
    Cereb Cortex; 2011 May; 21(5):999-1011. PubMed ID: 20843900
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dendritic-targeting GABA neurons in monkey prefrontal cortex: comparison of somatostatin- and calretinin-immunoreactive axon terminals.
    Melchitzky DS; Lewis DA
    Synapse; 2008 Jun; 62(6):456-65. PubMed ID: 18361442
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alterations of cortical GABA neurons and network oscillations in schizophrenia.
    Gonzalez-Burgos G; Hashimoto T; Lewis DA
    Curr Psychiatry Rep; 2010 Aug; 12(4):335-44. PubMed ID: 20556669
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Insights into the neurodevelopmental origin of schizophrenia from postmortem studies of prefrontal cortical circuitry.
    Beneyto M; Lewis DA
    Int J Dev Neurosci; 2011 May; 29(3):295-304. PubMed ID: 20797429
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia.
    Goff DC; Coyle JT
    Am J Psychiatry; 2001 Sep; 158(9):1367-77. PubMed ID: 11532718
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia.
    Lewis DA; Curley AA; Glausier JR; Volk DW
    Trends Neurosci; 2012 Jan; 35(1):57-67. PubMed ID: 22154068
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Postnatal development of parvalbumin- and GABA transporter-immunoreactive axon terminals in monkey prefrontal cortex.
    Erickson SL; Lewis DA
    J Comp Neurol; 2002 Jun; 448(2):186-202. PubMed ID: 12012429
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chandelier cells: shedding light on altered cortical circuitry in schizophrenia.
    Lewis DA
    Mol Psychiatry; 1998 Nov; 3(6):468-71, 466-7. PubMed ID: 9857967
    [No Abstract]   [Full Text] [Related]  

  • 59. Chandelier cartridges in the prefrontal cortex are reduced in isolation reared rats.
    Bloomfield C; French SJ; Jones DN; Reavill C; Southam E; Cilia J; Totterdell S
    Synapse; 2008 Aug; 62(8):628-31. PubMed ID: 18512213
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quercetin Reduces Cortical GABAergic Transmission and Alleviates MK-801-Induced Hyperactivity.
    Fan HR; Du WF; Zhu T; Wu YJ; Liu YM; Wang Q; Wang Q; Gu X; Shan X; Deng S; Zhu T; Xu TL; Ge WH; Li WG; Li F
    EBioMedicine; 2018 Aug; 34():201-213. PubMed ID: 30057312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.